ThromboGenics Delays Diabetic Retinopathy Study; On Track To File Ocriplasmin For Retinal Adhesions
This article was originally published in The Pink Sheet Daily
Executive Summary
Belgian company focuses on filing orciplasmin for U.S. and EU approval, and preparing for commercialization.